VYNE THERAPEUTICS INC (VYNE) Forecast, Price Target & Analyst Ratings

NASDAQ:VYNE • US92941V3087

Current stock price

0.61 USD
0 (-0.41%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VYNE THERAPEUTICS INC (VYNE).

Forecast Snapshot

Consensus Price Target

Price Target
$3.32
+ 443.44% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.18
Revenue Estimate
204K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.32
Upside
+ 443.44%
From current price of $0.61 to mean target of $3.32, Based on 10 analyst forecasts
Low
$2.02
Median
$3.32
High
$4.73

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for VYNE. The average price target is 3.32 USD. This implies a price increase of 443.44% is expected in the next year compared to the current price of 0.61.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VYNE Current Analyst RatingVYNE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

VYNE Historical Analyst RatingsVYNE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
78.00%
VYNE was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about VYNE.
In the previous month the buy percentage consensus was at a similar level.
VYNE was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-07-30HC Wainwright & Co.Downgrade Buy -> Neutral
2025-04-25HC Wainwright & Co.Maintains Buy -> Buy
2025-03-06HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-23HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-18BTIGInitiate Buy
2024-11-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-05HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-09HC Wainwright & Co.Reiterate Buy -> Buy
2024-05-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-29HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-30HC Wainwright & Co.Maintains Buy -> Buy
2023-08-14HC Wainwright & Co.Reiterate Buy -> Buy
2023-05-12Cantor FitzgeraldMaintains Overweight
2023-05-12HC Wainwright & Co.Reiterate Buy -> Buy
2023-04-19HC Wainwright & Co.Reiterate Buy
2023-03-30HC Wainwright & Co.Reiterate Buy
2023-03-14HC Wainwright & Co.Reiterate Buy
2022-08-10HC Wainwright & Co.Maintains Buy
2021-05-07HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.18
Revenue Estimate
204K
Revenue Q2Q
0.99%
EPS Q2Q
8.20%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

VYNE is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.18 USD and the consensus revenue estimate is 204.00K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
VYNE revenue by date.VYNE revenue by date.
424K
-11.67%		501K
18.16%		570K
13.77%		357K
-37.37%
-100.00%		51M102M
100.00%		153M
50.00%		204M
33.33%		229.5M
12.50%
EBITDA
YoY % growth
VYNE ebitda by date.VYNE ebitda by date.
-29.258M
14.53%		-43.633M
-49.13%		-29.726M
31.87%		-51.714M
-73.97%		-58.854M
-13.81%		-62.526M
-6.24%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
VYNE ebit by date.VYNE ebit by date.
-29.258M
14.70%		-43.637M
-49.15%		-29.749M
31.83%		-42.534M
-42.98%		-76.5M
-79.86%		-117.3M
-53.33%		-129.54M
-10.43%		-18.87M
85.43%		31.11M
264.86%		81.6M
162.30%		97.41M
19.38%
Operating Margin
VYNE operating margin by date.VYNE operating margin by date.
-6,900.47%-8,709.98%-5,219.12%-11,914.29%N/AN/A-254.00%-18.50%20.33%40.00%42.44%
EPS
YoY % growth
VYNE eps by date.VYNE eps by date.
-7.04
36.40%		-0.94
86.65%		-0.61
34.80%		-0.93
-52.27%		-1.68
-80.33%		-2.50
-48.48%		-2.70
-8.16%		-0.41
84.91%		0.56
237.50%		1.38
145.45%		1.28
-7.41%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.18
8.20%		-0.18
-41.23%		-0.18
-8.00%		-0.19
-71.63%
Revenue
Q2Q % growth		204K
0.99%		204K
195.65%		204K
20.71%		204K
56.92%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-8.262M
10.17%		-8.466M
-12.25%		-8.568M
-9.96%		-8.772M
-68.08%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VYNE Yearly Revenue VS EstimatesVYNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2029 2030 2031 2032 2033 50M 100M 150M 200M
VYNE Yearly EPS VS EstimatesVYNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -50 -100 -150 -200

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-59.75%
EPS Next 5 Year
5.94%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-25.99%
Revenue Next 5 Year
219.58%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-19.69%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

VYNE THERAPEUTICS INC / VYNE Forecast FAQ

What is the price target for VYNE stock?

10 analysts have analysed VYNE and the average price target is 3.32 USD. This implies a price increase of 443.44% is expected in the next year compared to the current price of 0.61.

Can you provide the upcoming earnings date for VYNE THERAPEUTICS INC?

VYNE THERAPEUTICS INC (VYNE) will report earnings on 2026-05-06.

What are the consensus estimates for VYNE stock next earnings?

The consensus EPS estimate for the next earnings of VYNE THERAPEUTICS INC (VYNE) is -0.18 USD and the consensus revenue estimate is 204.00K USD.

What is the consensus rating for VYNE THERAPEUTICS INC (VYNE) stock?

The consensus rating for VYNE THERAPEUTICS INC (VYNE) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.